285 related articles for article (PubMed ID: 12700520)
1. [Primary biliary cirrhosis].
Corpechot C
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):320-4. PubMed ID: 12700520
[No Abstract] [Full Text] [Related]
2. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
Corpechot C; Chazouilleres O
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
[No Abstract] [Full Text] [Related]
3. Management of autoimmune and cholestatic liver disorders.
Krok KL; Munoz SJ
Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
5. [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
Thimme R; Opitz OG; Kreisel W
Dtsch Med Wochenschr; 2002 Sep; 127(36):1823-6. PubMed ID: 12215926
[No Abstract] [Full Text] [Related]
6. Acute seronegative autoimmune hepatitis.
Ozaslan E; Samsar U; Erden E
Hepatogastroenterology; 2010; 57(98):334-5. PubMed ID: 20583438
[TBL] [Abstract][Full Text] [Related]
7. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
Lim AG; Wolfhagen FH; Verma A; van Buuren HR; Jazrawi RP; Levy JH; Northfield TC; Schalm SW
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):155-61. PubMed ID: 9058626
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Zenia M; Toda G
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1763-7. PubMed ID: 10581761
[No Abstract] [Full Text] [Related]
9. Guidelines for therapy of autoimmune liver disease.
Ishibashi H; Komori A; Shimoda S; Gershwin ME
Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
[TBL] [Abstract][Full Text] [Related]
10. [Primary biliary cirrhosis (PBC)].
Rautiainen H
Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
[TBL] [Abstract][Full Text] [Related]
11. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
12. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
Kaplan MM; Poupon R
Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
[No Abstract] [Full Text] [Related]
13. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
14. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
Burnevich EZ; Ignatova TM
Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
[No Abstract] [Full Text] [Related]
15. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
[TBL] [Abstract][Full Text] [Related]
16. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
18. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
[No Abstract] [Full Text] [Related]
19. [Primary biliary cirrhosis].
Kuiper EM; den Ouden-Muller JW; van Buuren HR
Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324
[TBL] [Abstract][Full Text] [Related]
20. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
Kayacetin E; Köklü S; Temuçin T
Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
